Sun Pharmaceutical Industries Share Price Today - Live Blog for June 12, 2025

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.16% in its share price, and it currently trades at ₹1,683.70 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.08% uptick in its share price. As a result, it's now actively trading at ₹1,687.10 per share, making it an attractive option for investors.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.30%, with the current market value at ₹1,685.85 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.04% increase and currently trading at ₹1,691.45 per share. This upward trajectory is turning heads in the market.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.19% in its share price, and it currently trades at ₹1,690.05 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.14% surge in its share price and is presently trading at ₹1,693.20. The increased investor interest is driving this surge.

Sun Pharmaceutical Industries Ltd observed a -0.06% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,692.55. The stock has a PE ratio of 37.0600, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.18% drop, and it's now trading at ₹1,692.90 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.51% decline, and it currently trades at ₹1,697.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.01% increase and currently trading at ₹1,706.75 per share. This upward trajectory is turning heads in the market.

With a -0.21% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,706.05. Investors should examine the factors driving this decline. The stock's PE ratio is 37.0600, whereas the industry PE ratio stands at 34.5835.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.02%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,709.60, but investors are assessing whether this is a temporary dip or a long-term trend.

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.12% uptick in its share price. As a result, it's now actively trading at ₹1,710.00 per share, making it an attractive option for investors.

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.02% uptick in its share price. As a result, it's now actively trading at ₹1,708.70 per share, making it an attractive option for investors.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.03% decline and is currently trading at ₹1,708.90 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Sun Pharmaceutical Industries Ltd witnessed a -0.03% decrease in its share price, and it is currently trading at ₹1,708.90. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 37.0600, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.01%, and as of now, it's trading at ₹1,707.80 per share. This upward trajectory is attracting keen interest from investors.

Sun Pharmaceutical Industries Ltd shares saw a -0.03% decrease, reaching a current market price of ₹1,708.55. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 37.0600, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.06%. At this moment, it's actively trading at ₹1,710.80, presenting an enticing opportunity for those in the market.

Sun Pharmaceutical Industries Ltd witnessed a -0.33% decrease in its share price, and it is currently trading at ₹1,709.70. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 37.0600, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.12% decline, and it currently trades at ₹1,717.80 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.12% drop, and it's now trading at ₹1,718.15 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.15% increase in its share price and is currently trading at ₹1,720.30. This remarkable performance has caught the eye of investors.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.59%, a development that warrants careful analysis. Presently trading at ₹1,715.25, investors are assessing whether this presents an opportunity or a risk.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.85% increase and currently trading at ₹1,725.40 per share. Investors are taking notice of this upward momentum.

After a notable 6.93% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,710.85. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.